COG2 activators are a specialized category of compounds designed to modulate the activity of the COG2 protein, which is a component of the Conserved Oligomeric Golgi (COG) complex. This multi-subunit complex is integral to the proper function and maintenance of the Golgi apparatus, an essential organelle involved in modifying, sorting, and packaging proteins and lipids for secretion or use within the cell. The COG complex is particularly implicated in the process of vesicular trafficking, where it orchestrates the tethering and fusion of vesicles transporting a variety of macromolecules. COG2 activators operate by increasing the activity or stability of the COG2 protein within this complex, thereby potentially influencing the efficiency and fidelity of intracellular transport processes.
The development of COG2 activators requires an in-depth understanding of the protein's role within the COG complex and the mechanistic details of its interactions with other subunits and cargo molecules. The molecular design of such activators often relies on insights gleaned from structural biology, which may reveal the three-dimensional conformation of COG2 and suggest strategies for enhancing its function. These activators might be small molecules, peptides, or other types of chemical agents capable of binding to COG2 in a way that promotes or stabilizes its active conformation, thereby augmenting its role within the COG complex. Researchers utilize a variety of techniques, such as high-throughput screening, computational modeling, and biophysical assays, to identify and optimize compounds that can effectively target COG2.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of vitamin A, might potentially stimulate the transcriptional activity necessary for COG2 upregulation, given its known role in cell differentiation and proliferation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid, could potentially stimulate the production of COG2 by triggering cellular stress responses, a mechanism known to increase the expression of certain genes. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estradiol, an estrogen hormone, might potentially stimulate the production of COG2 via estrogen receptor-mediated gene induction, given the hormone's known role in gene expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, known for its ability to raise cellular cAMP levels and thereby activate protein kinase A (PKA), might potentially stimulate the production of COG2 as part of a broader impact on gene expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin, a hormone central to cellular metabolism and growth, might potentially stimulate the production of COG2 via downstream effects of insulin receptor signaling pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor known to alter the methylation state of DNA, could potentially increase COG2 expression by causing global changes in gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, might potentially stimulate COG2 expression by triggering changes in the acetylation state of histones, leading to a more open chromatin structure and increased gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a short-chain fatty acid, might potentially stimulate COG2 expression by inhibiting histone deacetylase, leading to a more loose chromatin structure and increased gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, known as an mTOR inhibitor, could potentially stimulate the production of COG2 via the downstream effects of inhibiting the mTOR signaling pathway, a key regulator of cell growth and proliferation. | ||||||